SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Alrutz Michael Albert

(Last) (First) (Middle)
C/O CHIMERIX, INC.
2505 MERIDIAN PARKWAY, SUITE 340

(Street)
DURHAM NC 27713

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
02/05/2019
3. Issuer Name and Ticker or Trading Symbol
CHIMERIX INC [ CMRX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Principal Executive Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 56,645(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) (2) 06/01/2022 Common Stock 1,485 2.38 D
Stock Option (Right to Buy) (2) 01/28/2024 Common Stock 9,000 18.75 D
Stock Option (Right to Buy) (2) 08/26/2024 Common Stock 20,000 25.75 D
Stock Option (Right to Buy) (2) 01/28/2025 Common Stock 28,000 39.41 D
Stock Option (Right to Buy) 08/01/2015(3) 08/01/2025 Common Stock 15,000 53.74 D
Stock Option (Right to Buy) 01/08/2016(3) 01/08/2026 Common Stock 178,000 8.06 D
Stock Option (Right to Buy) 01/24/2017(3) 01/24/2027 Common Stock 45,750 5.14 D
Stock Option (Right to Buy) 01/25/2018(3) 01/25/2028 Common Stock 135,000 4.68 D
Stock Option (Right to Buy) 01/23/2019(3) 01/23/2029 Common Stock 176,000 2.41 D
Explanation of Responses:
1. Amount includes (i) 12,500 unvested shares pursuant to a restricted stock unit award issued on May 9, 2016 and (ii) 11,437 unvested shares pursuant to a restricted stock unit award issued on January 24, 2017.
2. Fully vested and exercisable.
3. 1/48th of the shares will vest each month over a four year period following the vesting commencement date.
Remarks:
/s/ Michael Alrutz 02/07/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.